Global Cell Culture Media Market
Market Report I 2025-03-01 I 350 Pages I Data Bridge Market Research
Global cell culture media market is expected to reach USD 23.37 billion by 2035 from USD 6.94 billion in 2024, growing with a CAGR of 11.70% in the forecast period of 2025 to 2035
Market Segmentation:
Global Cell Culture Media Market Segmentation, By Type (Chemically Defined Media, Classical Media, Serum-Free Media, Specialty Media, Stem Cell Media, Lysogeny Broth (LB), Custom Media Formulation, and Others), Application (Biopharmaceutical Production, Drug Screening & Development, Diagnostics, Regenerative Medicine & Tissue Engineering, and Others), End-User (Biopharmaceutical Companies, Biotechnology Organizations, Academic and Research Laboratories, Hospitals, Diagnostic Centers, Cell Banks, Forensic Laboratories, and Others), Distribution Channel (Direct Tenders, Third Party Distribution, and Retails Sales), Countries (U.S., Canada, and Mexico, Germany, U.K., France, Netherlands, Spain, Switzerland, Belgium, Italy, Russia, Turkey, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, and rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa) - Industry Trends and Forecast to 2035
Overview of Global Cell Culture Media Market Dynamics:
Driver
- Increasing Focus on Personalized Medicine
Restrain
- Risks Associated with Contamination
Opportunity
- Rising Collaboration and Partnerships
Market Players:
The key market players operating in the global cell culture media market are listed below:
- Thermo Fisher Scientific Inc.
- Merck KGaA (MilliporeSigma)
- Danaher Corporation (Cytiva)
- Lonza
- Sartorius AG
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- GE Healthcare
- BD (Becton, Dickinson and Company)
- Himedia Laboratories
- Promocell
- Sera Scandia A/S
- VWR International, LLC
- Elex Biological Products (Shanghai) Co., Ltd.
- Vitro Diagnostics Inc.
- Stemcell Technologies, Inc.
- Caisson Labs Inc.
- Koh Jin-Bio Co., Ltd.
- InvivoGen
- Fujifilm Holdings America Corporation
- Takara Bio Inc.
TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW OF THE GLOBAL CELL CULTURE MEDIA MARKET 26
1.4 CURRENCY AND PRICING 27
1.5 LIMITATIONS 27
1.6 MARKETS COVERED 28
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GEOGRAPHICAL SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 DBMR TRIPOD DATA VALIDATION MODEL 33
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.6 MULTIVARIATE MODELLING 37
2.7 MARKET APPLICATION COVERAGE GRID 38
2.8 PRODUCT LIFELINE CURVE 38
2.9 DBMR MARKET POSITION GRID 39
2.10 VENDOR SHARE ANALYSIS 40
2.11 SECONDARY SOURCES 41
2.12 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 46
4.1 PORTER'S FIVE FORCES 49
4.2 PESTEL ANALYSIS 50
5 GLOBAL CELL CULTURE MEDIA MARKET: REGULATIONS 51
6 MARKET OVERVIEW 56
6.1 DRIVERS 58
6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE 58
6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE 58
6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS 59
6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT 60
6.2 RESTRAINTS 60
6.2.1 RISKS ASSOCIATED WITH CONTAMINATION 60
6.2.2 HIGH COST OF PRODUCTION 61
6.3 OPPORTUNITIES 61
6.3.1 RISING COLLABORATION AND PARTNERSHIPS 61
6.3.2 INCREASING DEMAND FOR BIOPHARMACEUTICALS AND VACCINES 62
6.3.3 INNOVATIONS IN 3D CELL CULTURE 63
6.4 CHALLENGES 64
6.4.1 COMPLEXITY OF MEDIA FORMULATION 64
6.4.2 INTENSE MARKET COMPETITION 65
7 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE 66
7.1 OVERVIEW 67
7.2 CHEMICALLY DEFINED MEDIA CHEMICALLY DEFINED MEDIA 70
7.3 CLASSICAL MEDIA 71
7.4 SERUM-FREE MEDIA 72
7.5 SPECIALTY MEDIA 73
7.6 STEM CELL MEDIA 74
7.7 LYSOGENY BROTH (LB) 75
7.8 CUSTOM MEDIA FORMULATION 75
7.9 OTHERS 76
8 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION 77
8.1 OVERVIEW 78
8.2 BIOPHARMACEUTICAL PRODUCTION 81
8.3 DRUG SCREENING & DEVELOPMENT 82
8.4 DIAGNOSTICS 83
8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING 84
8.6 OTHERS 85
9 GLOBAL CELL CULTURE MEDIA MARKET, BY END-USER 86
9.1 OVERVIEW 87
9.2 BIOPHARMACEUTICAL COMPANIES 90
9.3 BIOTECHNOLOGY ORGANIZATIONS 91
9.4 ACADEMIC AND RESEARCH LABORATORIES 92
9.5 HOSPITALS 92
9.6 DIAGNOSTIC CENTERS 93
9.7 CELL BANKS 93
9.8 FORENSIC LABORATORIES 94
9.9 OTHERS 94
10 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL 95
10.1 OVERVIEW 96
10.2 DIRECT TENDERS 99
10.3 THIRD PARTY DISTRIBUTION 100
10.4 RETAILS SALES 101
11 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION 102
11.1 OVERVIEW 103
11.2 NORTH AMERICA 106
11.2.1 U.S. 110
11.2.2 CANADA 113
11.2.3 MEXICO 116
11.3 EUROPE 119
11.3.1 GERMANY 123
11.3.2 U.K. 126
11.3.3 FRANCE 129
11.3.4 NETHERLANDS 132
11.3.5 SPAIN 135
11.3.6 SWITZERLAND 138
11.3.7 BELGIUM 141
11.3.8 ITALY 144
11.3.9 RUSSIA 147
11.3.10 TURKEY 150
11.3.11 REST OF EUROPE 153
11.4 SOUTH AMERICA 154
11.4.1 BRAZIL 158
11.4.2 ARGENTINA 161
11.4.3 REST OF SOUTH AMERICA 164
11.5 MIDDLE EAST AND AFRICA 165
11.5.1 SOUTH AFRICA 169
11.5.2 SAUDI ARABIA 172
11.5.3 U.A.E 175
11.5.4 EGYPT 178
11.5.5 ISRAEL 181
11.5.6 REST OF MIDDLE EAST AND AFRICA 184
11.6 ASIA-PACIFIC 185
11.6.1 CHINA 190
11.6.2 JAPAN 193
11.6.3 INDIA 196
11.6.4 SOUTH KOREA 199
11.6.5 AUSTRALIA 203
11.6.6 SINGAPORE 206
11.6.7 THAILAND 209
11.6.8 MALAYSIA 212
11.6.9 INDONESIA 215
11.6.10 PHILIPPINES 218
11.6.11 REST OF ASIA-PACIFIC 221
12 GLOBAL CELL CULTURE MEDIA MARKET: COMPANY LANDSCAPE 222
12.1 COMPANY SHARE ANALYSIS: GLOBAL 222
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 223
12.3 COMPANY SHARE ANALYSIS: EUROPE 224
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 225
13 SWOT ANALYSIS 226
14 COMPANY PROFILE 227
14.1 THERMO FISHER SCIENTIFIC INC. 227
14.1.1 COMPANY SNAPSHOT 227
14.1.2 REVENUE ANALYSIS 227
14.1.3 COMPANY SHARE ANALYSIS 228
14.1.4 PRODUCT PORTFOLIO 228
14.1.5 RECENT DEVELOPMENT 230
14.2 MERCK KGAA 231
14.2.1 COMPANY SNAPSHOT 231
14.2.2 REVENUE ANALYSIS 231
14.2.3 COMPANY SHARE ANALYSIS 232
14.2.4 PRODUCT PORTFOLIO 232
14.2.5 RECENT DEVELOPMENTS 233
14.3 DANAHER CORPORATION (CYTIVA) 235
14.3.1 COMPANY SNAPSHOT 235
14.3.2 REVENUE ANALYSIS 235
14.3.3 COMPANY SHARE ANALYSIS 236
14.3.4 PRODUCT PORTFOLIO 236
14.3.5 RECENT DEVELOPMENTS 238
14.4 SARTORIUS AG 240
14.4.1 COMPANY SNAPSHOT 240
14.4.2 REVENUE ANALYSIS 240
14.4.3 COMPANY SHARE ANALYSIS 241
14.4.4 PRODUCT PORTFOLIO 241
14.4.5 RECENT DEVELOPMENTS 244
14.5 LONZA 247
14.5.1 COMPANY SNAPSHOT 247
14.5.2 REVENUE ANALYSIS 247
14.5.3 COMPANY SHARE ANALYSIS 248
14.5.4 PRODUCT PORTFOLIO 248
14.5.5 RECENT DEVELOPMENT 248
14.6 CORNING INCORPORATED 249
14.6.1 COMPANY SNAPSHOT 249
14.6.2 REVENUE ANALYSIS 249
14.6.3 COMPANY SHARE ANALYSIS 250
14.6.4 PRODUCT PORTFOLIO 250
14.6.5 RECENT UPDATES 253
14.7 AJINOMOTO CO., INC 254
14.7.1 COMPANY SNAPSHOT 254
14.7.2 REVENUE ANALYSIS 254
14.7.3 PRODUCT PORTFOLIO 255
14.7.4 RECENT DEVELOPMENT 256
14.8 AKRON BIOTECH 257
14.8.1 COMPANY SNAPSHOT 257
14.8.2 PRODUCT PORTFOLIO 257
14.8.3 RECENT DEVELOPMENTS 257
14.9 BD 259
14.9.1 COMPANY SNAPSHOT 259
14.9.2 REVENUE ANALYSIS 259
14.9.3 PRODUCT PORTFOLIO 260
14.9.4 RECENT UPDATES 263
14.10 BIO-RAD LABORATORIES, INC. 265
14.10.1 COMPANY SNAPSHOT 265
14.10.2 REVENUE ANALYSIS 265
14.10.3 PRODUCT PORTFOLIO 266
14.10.4 RECENT DEVELOPMENT 268
14.11 CAISSON LABS INC. 269
14.11.1 COMPANY SNAPSHOT 269
14.11.2 PRODUCT PORTFOLIO 269
14.11.3 RECENT UPDATES 269
14.12 CELL APPLICATION, INC. 270
14.12.1 COMPANY SNAPSHOT 270
14.12.2 PRODUCT PORTFOLIO 270
14.12.3 RECENT UPDATES 270
14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD. 271
14.13.1 COMPANY SNAPSHOT 271
14.13.2 PRODUCT PORTFOLIO 271
14.13.3 RECENT DEVELOPMENT 273
14.14 FUJIFILM HOLDINGS CORPORATION 274
14.14.1 COMPANY SNAPSHOT 274
14.14.2 REVENUE ANALYSIS 274
14.14.3 PRODUCT PORTFOLIO 275
14.14.4 RECENT UPDATES 279
14.15 HIMEDIA LABORATORIES 281
14.15.1 COMPANY SNAPSHOT 281
14.15.2 PRODUCT PORTFOLIO 281
14.15.3 RECENT UPDATES 283
14.16 KOH JIN-BIO CO., LTD. 284
14.16.1 COMPANY SNAPSHOT 284
14.16.2 PRODUCT PORTFOLIO 284
14.16.3 RECENT UPDATES 285
14.17 PAN-BIOTECH 286
14.17.1 COMPANY SNAPSHOT 286
14.17.2 PRODUCT PORTFOLIO 286
14.17.3 RECENT UPDATES 288
14.18 PROMOCELL GMBH 289
14.18.1 COMPANY SNAPSHOT 289
14.18.2 PRODUCT PORTFOLIO 289
14.18.3 RECENT UPDATES 291
14.19 SERA-SCANDIA A/S 293
14.19.1 COMPANY SNAPSHOT 293
14.19.2 PRODUCT PORTFOLIO 293
14.19.3 RECENT DEVELOPMENTS 293
14.20 STEMCELL TECHNOLOGIES 294
14.20.1 COMPANY SNAPSHOT 294
14.20.2 PRODUCT PORTFOLIO 294
14.20.3 RECENT DEVELOPMENT 297
14.21 TAKARA BIO INC. 298
14.21.1 COMPANY SNAPSHOT 298
14.21.2 REVENUE ANALYSIS 298
14.21.3 PRODUCT PORTFOLIO 299
14.21.4 RECENT DEVELOPMENTS 304
15 QUESTIONNAIRE 305
16 RELATED REPORTS 308
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.